Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
297 GBX | +0.68% | -8.05% | -15.74% |
Apr. 02 | MaxCyte inks deal with Be Bio; Orcadian firms farmout | AN |
Apr. 02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- Official Publications